'The state government is putting Maharashtrians in danger by letting people escape institutional quarantine mandate for the sake of their personal vasuli'
In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".
Patanjali continues to take its peers head on.
WHO says the regulatory procedures in place for the licencing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute.
The regulator, which is planning to allow first phase of human clinical trials soon, will make registration of clinical research organisations and ongoing clinical trials mandatory.
These small-scale entrepreneurs offer luxury goods and services that eager customers are still willing to pay for.
Tackle your hair and skin problems with expert help from Dr Dinesh Jain.
Companies like Shanta Biotech, Panacea Biotec and Serum Institute of India are among the leading vaccine makers which have not been able to file any fresh application to the WHO due to this temporary de-recognition of the country's drug regulatory system. The WHO pre-qualification is essential for companies to supply vaccines to national immunisation programmes funded by the WHO or UNICEF outside the country.
News of all that transpired on and off the football field.
'The more seriously ill you are from heart disease, the more seriously ill you could get from infection with COVID-19.'
President A P J Abdul Kalam asked the Indian companies on Friday to tap the vast potential for health care products in the international market by maintaining competitive pricing and high quality.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
India could offer a train track to China to run a bullet train besides easy terms to set up industrial parks.
Too much exercise and eating disorders are some of the underlying factors that may affect fertility in women, says gynaecologist Dr Archana Dhawan Bajaj,
Researchers at the Queen's University in Belfast have found that young men, who take the anti-impotence drug recreationally, could be damaging their sperm quality, thus spoiling their chances of starting a family.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
India consistently ranked among the top three countries whose products were rejected for import by the regulator.
The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.
The Uttar Pradesh Food and Drug Administration on Tuesday said it has found detergent in one of the samples of Mother Dairy's milk packets, a claim contested by the Delhi-based company.
The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Anxiety, depression, hormonal changes are just some of the reasons says neurologist Dr Pruthviraj Dabarase.
Unhappy with Chinese machinery and raw materials they have been importing so far, Pakistani pharmaceutical companies are now longing to increase their business ties with India, and asked New Delhi to relax the "stringent visa norms".
'You might hate him, but it will be an honest portrayal.'
The growth prospects are particularly high for Indian companies in the speciality and complex generic drugs segment in the US, the report said.
He will call for 'an end to the politics of resistance and retribution', a senior aide said.
Under MRA, Japan is to recognise Indian medical degrees and treat the country's doctors and other medical personnel on par with its own.
Currently, Himalaya sells 250 products across the globe.
'... And I don't think it really is that despite a lot going wrong.' 'Naiveté or stupidity or trusting the wrong person, the outcome is the same, which is that the group has gone to trash.' 'I'm not OK with people saying I had a role to play in crooking the system, which is not what I did.'
Food and grocery a favourite category for e-commerce players.
'It's a matter of great pride that no student of Army Goodwill Schools has ever joined terrorism.'
In fresh troubles for Nestle over safety standards of its famous Maggi noodle brand, the Uttrakhand Food Safety Department has collected samples of the 'two-minute' noodles from the company's Pantanagar plant and other places in the state.
Thanks to technological support provided by BlinkIN, a Bengaluru-based intelligent visual-assistance company, engineers in Wuhan were able to remotely install air ventilation systems in two hospitals in Wuhan, the epicentre of the coronavirus pandemic, reports Peerzada Abrar.
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
The Indian pharmaceutical players have the potential to corner about 25 per cent of the generic market amounting to $3.75 billion by 2007-08 through leveraging their low cost and technology advantage, according to Rabo India Finance report.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances